Financial Performance - Net sales for FY 2024 increased by 12% to $12,181,971 from $10,885,154 in FY 2023[2] - Net income rose to $3,250,875 ($0.71 per share) in 2024, compared to $2,581,370 ($0.56 per share) in 2023[2] - Income from operations increased to $3,646,789 in 2024, compared to $2,863,032 in 2023[5] - Investment income rose to $434,679 in 2024 from $306,651 in 2023[6] Sales Performance - Sales of cosmetic ingredients increased by 32%, while medical lubricants saw a 16% rise, driven by higher demand in China[3] - Pharmaceutical sales decreased by 5% in 2024 due to a supply disruption of Renacidin, impacting sales until supply levels resumed[3] Costs and Expenses - Total costs and expenses for FY 2024 were $8,535,182, up from $8,022,122 in FY 2023[5] Assets and Equity - Total assets increased to $13,797,335 in 2024, up from $12,922,838 in 2023[8] - Stockholders' equity grew to $11,882,866 in 2024, compared to $11,388,582 in 2023[8] - Current liabilities increased to $1,914,469 in 2024 from $1,534,256 in 2023[8]
United-Guardian(UG) - 2024 Q4 - Annual Results